Chemical activators of C1orf228 include a range of compounds that can initiate intracellular signaling cascades, resulting in the functional activation of the protein. Forskolin is one such activator, which directly stimulates adenylyl cyclase, thereby increasing the levels of cyclic AMP (cAMP) within the cell. Elevated cAMP can then activate protein kinase A (PKA), which in turn phosphorylates C1orf228, leading to its activation. Similarly, Dibutyryl-cAMP and 8-Bromo-cAMP, both cAMP analogs, act within the same pathway to elevate PKA activity, which can directly phosphorylate and activate C1orf228. Ionomycin operates by increasing intracellular calcium levels, which can activate a variety of calcium-dependent kinases capable of phosphorylating C1orf228. Thapsigargin also raises intracellular calcium by inhibiting the SERCA pump, thereby inducing a cascade that can lead to the activation of C1orf228 through phosphorylation by calcium-responsive kinases.
In another pathway, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is known to phosphorylate a broad spectrum of substrates, including C1orf228, culminating in its activation. Compounds such as Calyculin A and Okadaic Acid prevent the dephosphorylation of proteins by inhibiting protein phosphatases 1 and 2A, consequently maintaining C1orf228 in a phosphorylated, active state. Anisomycin activates stress-activated protein kinases, which can also phosphorylate C1orf228, leading to activation. Growth factors like Epidermal Growth Factor (EGF) stimulate the MAPK/ERK pathway, which has numerous downstream targets, including the machinery that can phosphorylate C1orf228. Insulin triggers the PI3K/Akt pathway, another signaling avenue with the potential to activate C1orf228 through kinase-mediated phosphorylation. Finally, Isoproterenol, by acting as a β-adrenergic agonist, increases cAMP and subsequently PKA activity, which is yet another route through which C1orf228 can be phosphorylated and activated. Each of these chemicals, through their unique mechanisms, converge on the phosphorylation and activation of C1orf228, highlighting the complex interplay of signaling pathways within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels, which may activate calmodulin-dependent kinases that can phosphorylate and activate C1orf228. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates including C1orf228, resulting in its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, keeping proteins like C1orf228 in a phosphorylated and thus active state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, which prevents the dephosphorylation of proteins including C1orf228, maintaining its active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases, which could phosphorylate and activate C1orf228. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt pathway, which may result in the phosphorylation and activation of C1orf228 through downstream effects. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump, causing a rise in cytosolic calcium, which can activate kinases that phosphorylate and activate C1orf228. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, elevates PKA activity, which can phosphorylate and activate C1orf228. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP acts similarly to cAMP, leading to PKA activation, which in turn can phosphorylate and activate C1orf228. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a β-adrenergic agonist, increases cAMP levels, leading to the activation of PKA, which can phosphorylate and activate C1orf228. | ||||||